Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives, Dan Lynch, and ...

The EU 15% tariff will raise prices on European consumer brands from luxury, autos, food and beauty. This could reduce demand ...

Bain is closing its business in Johannesburg, likely bringing to an end a yearslong battle to try and restore its reputation.

The Kansas City Chiefs should add to their defensive end room by selecting Miami Hurricanes pass rusher Rueben Bain Jr. in ...

Bristol Myers Squibb is spinning off a fresh company armed with five autoimmune disease drugs and $300 million in Bain ...

BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus ...

Thank you to Keeps for sponsoring this video! Head to to get a special offer. Want to produce documentaries like this one?

The Cleveland Browns have had their problems recently, but one area of the roster that's stood out is the defensive line.

Bain shuts South Africa consultancy after state capture scandalJohannesburg office shifts to global services support ...

Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...

The newly formed biotech launches with five promising autoimmune candidates, $300 million in funding, and leadership from ...